Cytochrome P-450 CYP2E1 Inhibitors (moderate)
DBCAT002631Pharmacologic class
A DrugBank category of 3 drugs. 3 of them are approved.
- Also known as
- CYP2E1 Inhibitors (moderate) · Moderate CYP2E1 Inhibitors
What you can answer from here — as of May 20, 2021
Which targets do Cytochrome P-450 CYP2E1 Inhibitors (moderate) share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account